Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of HFCWO Via The Vest® Airway Clearance System in Addition to NIRT in the Treatment of Patient With Acute Respiratory Failure and Hypersecretion: Monocentric, Parallel Group, Controlled Randomized Clinical Trial

NCT05751707 is registered in ClinicalTrials.gov with Raffaele Scala as lead sponsor.

NCT NCT05751707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05751707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of HFCWO Via The Vest® Airway Clearance System in Addition to NIRT in the Treatment of Patient With Acute Respiratory Failure and Hypersecretion: Monocentric, Parallel Group, Controlled Randomized Clinical Trial
Lead sponsor
Raffaele Scala
Phase
Not applicable
Overall status
Unknown status
Start date
December 24, 2022
Completion date
December 24, 2024
Enrollment
88 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory failure, acute-on-chronic respiratory failure, airway clearance impairment